ZYFLO CR (Chiesi USA, Inc.)
Welcome to the PulseAid listing for the ZYFLO CR drug offered from Chiesi USA, Inc.. This 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Chiesi USA, Inc. |
| NON-PROPRIETARY NAME: | zileuton |
| SUBSTANCE NAME: | ZILEUTON |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, MULTILAYER, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-05-30 |
| END MARKETING DATE: | 0000-00-00 |
ZYFLO CR HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZYFLO CR from Chiesi USA, Inc. |
| LABELER NAME: | Chiesi USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 600(mg/1) |
| START MARKETING DATE: | 2007-05-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10122-902_73d2e42b-eba3-40fa-b1f8-2159cf49e41a |
| PRODUCT NDC: | 10122-902 |
| APPLICATION NUMBER: | NDA022052 |
Other ZILEUTON Pharmaceutical Manufacturers / Labelers:
